Literature DB >> 16709964

Ethnicity and adverse drug reactions.

Erik Eliasson.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16709964      PMCID： PMC1463978          DOI： 10.1136/bmj.332.7551.1163

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Molecular basis of ethnic differences in drug disposition and response.

Authors:  H G Xie; R B Kim; A J Wood; C M Stein
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 2.  Genetic susceptibility to adverse drug reactions.

Authors:  M Pirmohamed; B K Park
Journal:  Trends Pharmacol Sci       Date:  2001-06       Impact factor: 14.819

3.  Race and genomics.

Authors:  Richard S Cooper; Jay S Kaufman; Ryk Ward
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

4.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 5.  Beyond race: towards a whole-genome perspective on human populations and genetic variation.

Authors:  Morris W Foster; Richard R Sharp
Journal:  Nat Rev Genet       Date:  2004-10       Impact factor: 53.242

Review 6.  Priorities and standards in pharmacogenetic research.

Authors:  Anna C Need; Arno G Motulsky; David B Goldstein
Journal:  Nat Genet       Date:  2005-07       Impact factor: 38.330

7.  Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

Authors:  I Johansson; M Oscarson; Q Y Yue; L Bertilsson; F Sjöqvist; M Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

8.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Authors:  Mark J Rieder; Alexander P Reiner; Brian F Gage; Deborah A Nickerson; Charles S Eby; Howard L McLeod; David K Blough; Kenneth E Thummel; David L Veenstra; Allan E Rettie
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

9.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Authors:  Seth Hetherington; Arlene R Hughes; Michael Mosteller; Denise Shortino; Katherine L Baker; William Spreen; Eric Lai; Kirstie Davies; Abigail Handley; David J Dow; Mary E Fling; Michael Stocum; Clive Bowman; Linda M Thurmond; Allen D Roses
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

10.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.

Authors:  Q Y Yue; J O Svensson; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335
View more
  11 in total

1.  Pharmacovigilance in developing countries.

Authors:  Munir Pirmohamed; Kwame N Atuah; Alex N O Dodoo; Peter Winstanley
Journal:  BMJ       Date:  2007-09-08

Review 2.  Specific features of medicines safety and pharmacovigilance in Africa.

Authors:  Ambrose O Isah; Shanthi N Pal; Sten Olsson; Alexander Dodoo; Rachida Soulayami Bencheikh
Journal:  Ther Adv Drug Saf       Date:  2012-02

Review 3.  Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.

Authors:  Lateef Mohiuddin Khan
Journal:  Eur J Clin Pharmacol       Date:  2013-08-17       Impact factor: 2.953

4.  Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Omar I Saadah
Journal:  Saudi Pharm J       Date:  2012-10-06       Impact factor: 4.330

5.  Two cases of paralitic ileus in onco-hematologic patients.

Authors:  Francesca Carraro; Elisa Rivetti; Erica Romano; Franca Fagioli
Journal:  Pediatr Rep       Date:  2012-01-17

6.  A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.

Authors:  Rosliana Rosli; Long Chiau Ming; Noorizan Abd Aziz; Mohamed Mansor Manan
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

7.  Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.

Authors:  Xia Zhao; Xiao Yan Sheng; Christopher D Payne; Xin Zhang; Feng Wang; Yi Min Cui
Journal:  Clin Pharmacol Drug Dev       Date:  2020-09-17

8.  Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Huda M Alkreathy; Abdel-Moneim M Osman; Ahmed S Ali
Journal:  Saudi Pharm J       Date:  2014-10-31       Impact factor: 4.330

9.  Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.

Authors:  Alan O Vázquez-Alvarez; Lorena Michele Brennan-Bourdon; Ana Rosa Rincón-Sánchez; María Cristina Islas-Carbajal; Selene G Huerta-Olvera
Journal:  BMC Pharmacol Toxicol       Date:  2017-12-08       Impact factor: 2.483

10.  Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea.

Authors:  In Young Jung; Jung Ju Kim; Se Ju Lee; Jinnam Kim; Hye Seong; Wooyong Jeong; Heun Choi; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; Jung Won Park; June Myung Kim
Journal:  Biomed Res Int       Date:  2017-12-31       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.